BRAF and melanoma: Further works should assess the contribution of our newly identified mechanisms involving polyamine biosynthesis and EIF5A hypusination in the context of dynamic rewiring and adaptation of BRAF mutant melanoma upon BRAFi/MAPKi treatment.